Related Experiment Videos
cDNA microarray analysis reveals new candidate genes possibly linked to side effects under mycophenolate mofetil
Maria Shipkova1, Bettina Spielbauer, Antje Voland
1Zentralinstitut für Klinische Chemie und Laboratoriumsmedizin, Klinikum Stuttgart, Katharinenhospital, Kriegsbergstrasse 60, D-70174 Stuttgart, Germany. m.shipkova@klinikum-stuttgart.de
Transplantation
|October 27, 2004
Summary
Mycophenolate mofetil (MMF) down-regulates key genes in rats, potentially explaining side effects like anemia and oxidative stress. This study identified four candidate genes linked to MMF
Area of Science:
- Pharmacogenomics
- Immunosuppressant drug effects
- Animal models in drug research
Background:
- Mycophenolate mofetil (MMF), a prodrug of mycophenolic acid, is a widely used immunosuppressant.
- Common MMF side effects include anemia and diarrhea in 10%-15% of patients.
- Understanding the molecular mechanisms underlying MMF side effects is crucial for patient management.
Purpose of the Study:
- To investigate the impact of MMF on gene expression in the liver and gut of rats.
- To identify specific genes regulated by MMF that may correlate with observed side effects.
- To provide a molecular basis for understanding MMF-induced toxicity.
Main Methods:
- Wistar rats were orally administered MMF (40 mg/kg) or vehicle for 21 days.
- Gene expression analysis was performed on liver, jejunum, ileum, and colon tissues.
- DNA microarray and quantitative real-time PCR (qPCR) were employed to identify and validate gene regulation.
Main Results:
- MMF treatment led to significant down-regulation of major alpha-hemoglobin, polymeric immunoglobulin receptor, catalase, and CCAAT/enhancer protein alpha genes in rat livers.
- Down-regulation of these genes was confirmed across liver and various sections of the gut (jejunum, ileum, colon) via qPCR.
- Fold changes in down-regulation ranged from 4- to 10-fold for the identified genes.
Conclusions:
- Four candidate genes (major alpha-hemoglobin, polymeric immunoglobulin receptor, catalase, CCAAT/enhancer protein alpha) were identified as potentially linked to MMF side effects.
- Major alpha-hemoglobin down-regulation may contribute to anemia.
- Reduced polymeric immunoglobulin receptor, catalase, and CCAAT/enhancer protein alpha expression could be associated with mucosal protection and oxidative stress, respectively.